# Serum Concentration of Tranexamic Acid After Topical Administration in Massive Weight Loss Skin Reducing Surgery

> **NCT03101124** · PHASE2 · COMPLETED · sponsor: **St. Olavs Hospital** · enrollment: 36 (actual)

## Conditions studied

- Surgical Wound
- Bleeding

## Interventions

- **DRUG:** Tranexamic Acid 25 mg/ml for wound surface moistening
- **DRUG:** Tranexamic Acid 5 mg/ml as bolus in wound cavity
- **DRUG:** Tranexamic Acid Injectable Solution

## Key facts

- **NCT ID:** NCT03101124
- **Lead sponsor:** St. Olavs Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2018-02-28
- **Final completion:** 2018-02-28
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2019-08-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03101124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03101124, "Serum Concentration of Tranexamic Acid After Topical Administration in Massive Weight Loss Skin Reducing Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03101124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*